The Journal of Urology
Volume 177, Issue 3 , Pages 1047-1051 , March 2007

Durability and Cost-Effectiveness of Transurethral Needle Ablation of the Prostate as an Alternative to Transurethral Resection of the Prostate When α-Adrenergic Antagonist Therapy Fails

  • Derek J. Rosario

      Affiliations

    • Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
    • Corresponding Author InformationCorrespondence: Academic Urology Unit, Clinical Sciences (South), University of Sheffield, K Floor, Royal Hallamshire Hospital, Sheffield S10 2JF, United Kingdom.
    • ,
  • Joshua T. Phillips

      Affiliations

    • Department of Urology, Royal Hallamshire Hospital, Sheffield, United Kingdom
    • ,
  • Christopher R. Chapple

      Affiliations

    • Department of Urology, Royal Hallamshire Hospital, Sheffield, United Kingdom

Received 27 May 2006

References 

  1. Roehrborn CG, Issa MM, Bruskewitz RC, Naslund MJ, Oesterling JE, Perez-Marrero R, et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology. 1998;51:415
  2. Roehrborn CG, Burkhard FC, Bruskewitz RC, Issa MM, Perez-Marrero R, Naslund MJ, et al. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. J Urol. 1999;162:92
  3. Rosario DJ, Woo H, Potts KL, Cutinha PE, Hastie KJ, Chapple CR. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol. 1997;80:579
  4. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol. 1991;145:984
  5. Lim CS, Abrams P. The Abrams-Griffiths nomogram. World J Urol. 1995;13:34
  6. Naslund MJ, Carlson AM, Williams MJ. A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period. J Urol. 2005;173:2090
  7. Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989;320:1120
  8. Schulman CC, Zlotta AR. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience. Urology. 1995;45:28
  9. Griffiths D, Hofner K, van Mastrigt R, Rollema HJ, Spangberg A, Gleason D International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. Neurourol Urodyn. 1997;16:1
  10. Schatzl G, Madersbacher S, Djavan B, Lang T, Marberger M. Two-year results of transurethral resection of the prostate versus four ‘less invasive’ treatment options. Eur Urol. 2000;37:695
  11. Chapple CR, Issa MM, Woo H. Transurethral needle ablation (TUNA) (A critical review of radiofrequency thermal therapy in the management of benign prostatic hyperplasia). Eur Urol. 1999;35:119
  12. Zlotta AR, Giannakopoulos X, Maehlum O, Ostrem T, Schulman CC. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol. 2003;44:89
  13. Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004;171:2336
  14. Boyle P, Robertson C, Vaughan ED, Fitzpatrick JM. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. BJU Int. 2004;94:83
  15. Kaplan SA. Benign prostatic hyperplasia: patient perceptions and financial reality regarding the aging American prostate. J Urol. 2005;173:1852

 See Editorial on page 820.

PII: S0022-5347(06)02758-3

doi: 10.1016/j.juro.2006.10.042

The Journal of Urology
Volume 177, Issue 3 , Pages 1047-1051 , March 2007

Article Tools

* Image Usage & Resolution